Guided Therapeutics (GTHP) Profit After Tax (2016 - 2025)
Historic Profit After Tax for Guided Therapeutics (GTHP) over the last 16 years, with Q3 2025 value amounting to -$742000.0.
- Guided Therapeutics' Profit After Tax fell 1345.57% to -$742000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.2 million, marking a year-over-year decrease of 2606.75%. This contributed to the annual value of -$2.4 million for FY2024, which is 3072.51% up from last year.
- As of Q3 2025, Guided Therapeutics' Profit After Tax stood at -$742000.0, which was down 1345.57% from -$811000.0 recorded in Q2 2025.
- Over the past 5 years, Guided Therapeutics' Profit After Tax peaked at $68000.0 during Q3 2021, and registered a low of -$1.8 million during Q4 2022.
- Over the past 5 years, Guided Therapeutics' median Profit After Tax value was -$677000.0 (recorded in 2023), while the average stood at -$701412.1.
- Per our database at Business Quant, Guided Therapeutics' Profit After Tax crashed by 172058.82% in 2022 and then surged by 9995.37% in 2024.
- Quarter analysis of 5 years shows Guided Therapeutics' Profit After Tax stood at -$444000.0 in 2021, then plummeted by 306.98% to -$1.8 million in 2022, then soared by 78.64% to -$386000.0 in 2023, then crashed by 68.91% to -$652000.0 in 2024, then dropped by 13.8% to -$742000.0 in 2025.
- Its Profit After Tax was -$742000.0 in Q3 2025, compared to -$811000.0 in Q2 2025 and -$427.0 in Q1 2025.